Effect of oocyte selection, estradiol and antioxidant treatment on in vitro maturation of oocytes collected from prepubertal Boer goats

Lihua Lv; Wenbin Yue; Wenzhong Liu; Youshe Ren; Fuzhong Li; Kyung-Bon Lee; Smith, George W.
February 2010
Italian Journal of Animal Science;Feb2010, Vol. 9 Issue 1, p50
Academic Journal
Development of improved procedures for in vitro maturation of oocytes collected from prepubertal goats has applications for in vitro embryo production and accompanying strategies for genetic improvement. The objective of described studies was to determine the effects of oocyte grade, in vitro maturation time, antioxidant supplementation and concentrations of estradiol in the maturation medium on in vitro maturation of oocytes harvested from 1-6 mm follicles present on the ovaries (obtained from an abattoir) of 1-6-month old prepubertal Boer goats. Rates of progression to metaphase II were greater for Grade 1 oocytes (>3 compact layers of cumulus cells and evenly granulated cytoplasm) than Grade 2 oocytes (<3 layers cumulus cells and evenly granulated cytoplasm) and were lowest for Grade 3 oocytes (devoid of cumulus cells with abnormal cytoplasm). No significant effects of maturation for 24 vs 27 vs 30 h on progression of oocytes to metaphase II were observed. The addition of 5 μM β-mercaptoethanol to maturation medium increased the proportion of oocytes progressing to metaphase II and glutathione content in such oocytes, whereas supplementation with 10 mM hypotaurine was without effect. A significant inhibitory effect of in vitro maturation in the presence of high concentrations of estradiol (10 and 100 μg/mL) on progression to metaphase II was observed, and no effect was observed in response to 1 μg/mL estradiol treatment as compared with control. Results suggest that oocyte selection and β-mercaptoethanol supplementation can positively influence progression to metaphase II of oocytes harvested from ovaries of prepubertal goats, whereas high concentrations of estradiol are inhibitory to in vitro maturation.


Related Articles

  • luteinization.  // Hutchinson Dictionary of Scientific Biography;2005, p1 

    Development of an ovum in a ruptured Graafian follicle within the ovary, initiated by estrogen which in turn is activated by luteinizing hormone.

  • Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction. Sauer, Mark V.; Thornton II, Melvin H.; Schoolcraft, William; Frishman, Gary N. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2004, Vol. 9 Issue 5, p487 

    An open label, randomized, multi-centre study was performed to compare cetrorelix and leuprolide acetate for prevention of premature LH surge and to assess whether patients treated with cetrorelix benefit from addition of recombinant human (r-h)LH. Normo-ovutatory women (n = 74) undergoing...

  • Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Monsalve, Elena; Oviedo, Pilar J.; Garc�a-P�rez, Miguel Angel; Tar�n, Juan J.; Cano, Antonio; Hermenegildo, Carlos // Cardiovascular Research;Jan2007, Vol. 73 Issue 1, p66 

    Abstract: Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, is a novel cardiovascular risk factor produced by endothelial cells. ADMA levels are mainly regulated by the activity of dimethylarginine dimethylaminohydrolases (DDAH). Endothelial...

  • ESTRADIOL. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p485 

    Presents a comprehensive guide to laboratory and diagnostic tests for estradiol. Three types of estrogen present in the blood in measurable amounts; Use of the test in terms of assessment, evaluation and assisting in the diagnosis of a clinical condition; Nursing implications and procedure.

  • Cortical granules behave differently in mouse oocytes matured under different conditions. Xin-Yong Liu; Suo-Feng Mal; De-Qiang Miao; Dong-Jun Liu; Shorgan Bao; Jing-He Tan // Human Reproduction;Dec2005, Vol. 20 Issue 12, p3402 

    BACKGROUND: To better understand the differences between in vivo (IVO) and in vitro (IVM) matured oocytes, we studied the chronological changes in cortical granule (CG) distribution and nuclear progression during maturation, and the competence of CG release and embryo development of mouse...

  • Sorption of the Natural Endocrine Disruptors, Oestrone and 17β-Oestradiol in the Aquatic Environment. Bowman, Janet C.; Readman, James W.; Zhou, John L. // Environmental Geochemistry & Health;Mar2003, Vol. 25 Issue 1, p63 

    Adsorption of hydrophobic contaminants at the particle/water interface is one of the key processes controlling their fate in the aquatic environment. The sorption of the natural female hormones oestrone and 17β-oestradiol has been studied under simulated riverine conditions. Both the kinetics...

  • The thyroid C cells of ovariectomized rats treated with estradiol. Filipović, B.; Śo&cscute;ic-Jurjević, B.; Nestorović, N.; Stojanoski, M. Manojlovie; Kostić, N.; Milošević, V.; Sekulić, M. // Histochemistry & Cell Biology;Nov2003, Vol. 120 Issue 5, p409 

    The structure and function of thyroid C cells were studied in ovariectomized (Ovx) adult female rats without and after chronic treatment with estradiol dipropionate (EDP). A peroxidase–antiperoxidase method was applied for localization of calcitonin (CT) in the C cells. Morphometric...

  • Prevalence of Low Serum Estradiol Levels in Male Osteoporosis. Green Carlsen, C.; Hoeg Soerensen, T.; Fink Eriksen, E. // Osteoporosis International;Sep2000, Vol. 11 Issue 8, p697 

    : Estrogen deficiency has recently been implicated in the pathogenesis of male osteoporosis. We therefore investigated estrogen and androgen status in 63 men admitted to our clinic with the diagnosis of osteoporosis over a period of 2 years. The diagnosis was based on the presence of either...

  • Zumenon.  // Royal Society of Medicine: Medicines;2002, p581 

    This article presents information on Zumenon which is a proprietary, prescription-only preparation of the oestrogen of estradiol. It can be used in HRT, and is available as tablets.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics